Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-013882
Filing Date
2023-04-21
Accepted
2023-04-21 17:23:07
Documents
22

Document Format Files

Seq Description Document Type Size
1 DEF 14A axsm-20230421.htm   iXBRL DEF 14A 2556720
2 GRAPHIC img240217662_0.jpg GRAPHIC 39626
3 GRAPHIC img240217662_1.jpg GRAPHIC 966457
4 GRAPHIC img240217662_2.jpg GRAPHIC 274563
5 GRAPHIC img240217662_3.jpg GRAPHIC 275452
6 GRAPHIC img240217662_4.jpg GRAPHIC 470900
7 GRAPHIC img240217662_5.jpg GRAPHIC 301996
8 GRAPHIC img240217662_6.jpg GRAPHIC 673650
9 GRAPHIC img240217662_7.jpg GRAPHIC 378733
  Complete submission text file 0000950170-23-013882.txt   12521488

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20230421.xsd EX-101.SCH 7849
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20230421_lab.xml EX-101.LAB 24361
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20230421_pre.xml EX-101.PRE 12313
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axsm-20230421_def.xml EX-101.DEF 9971
16 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20230421_htm.xml XML 739154
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37635 | Film No.: 23837362
SIC: 2834 Pharmaceutical Preparations